iHuman Statistics
Total Valuation
iHuman has a market cap or net worth of $121.20 million. The enterprise value is -$36.88 million.
Important Dates
The last earnings date was Tuesday, March 25, 2025, before market open.
| Earnings Date | Mar 25, 2025 |
| Ex-Dividend Date | Apr 17, 2025 |
Share Statistics
iHuman has 52.02 million shares outstanding. The number of shares has decreased by -0.94% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 52.02M |
| Shares Change (YoY) | -0.94% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 70.75% |
| Owned by Institutions (%) | 0.37% |
| Float | 15.22M |
Valuation Ratios
The trailing PE ratio is 9.45.
| PE Ratio | 9.45 |
| Forward PE | n/a |
| PS Ratio | 0.97 |
| Forward PS | n/a |
| PB Ratio | 0.92 |
| P/TBV Ratio | 0.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.98, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.98 |
| Quick Ratio | 2.73 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.14 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.28% and return on invested capital (ROIC) is 4.64%.
| Return on Equity (ROE) | 10.28% |
| Return on Assets (ROA) | 3.13% |
| Return on Invested Capital (ROIC) | 4.64% |
| Return on Capital Employed (ROCE) | 7.40% |
| Revenue Per Employee | $161,359 |
| Profits Per Employee | $17,250 |
| Employee Count | 783 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 14.10 |
Taxes
In the past 12 months, iHuman has paid $1.65 million in taxes.
| Income Tax | 1.65M |
| Effective Tax Rate | 10.86% |
Stock Price Statistics
The stock price has increased by +37.06% in the last 52 weeks. The beta is 0.37, so iHuman's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +37.06% |
| 50-Day Moving Average | 2.06 |
| 200-Day Moving Average | 1.81 |
| Relative Strength Index (RSI) | 49.17 |
| Average Volume (20 Days) | 112,451 |
Short Selling Information
| Short Interest | 22,944 |
| Short Previous Month | 22,379 |
| Short % of Shares Out | 0.13% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.14 |
Income Statement
In the last 12 months, iHuman had revenue of $126.34 million and earned $13.51 million in profits. Earnings per share was $0.25.
| Revenue | 126.34M |
| Gross Profit | 87.70M |
| Operating Income | 9.85M |
| Pretax Income | 23.18M |
| Net Income | 13.51M |
| EBITDA | 11.45M |
| EBIT | 9.85M |
| Earnings Per Share (EPS) | $0.25 |
Full Income StatementBalance Sheet
The company has $160.12 million in cash and $2.04 million in debt, giving a net cash position of $158.08 million or $3.04 per share.
| Cash & Cash Equivalents | 160.12M |
| Total Debt | 2.04M |
| Net Cash | 158.08M |
| Net Cash Per Share | $3.04 |
| Equity (Book Value) | 131.64M |
| Book Value Per Share | 2.53 |
| Working Capital | 121.70M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 69.42%, with operating and profit margins of 7.80% and 10.69%.
| Gross Margin | 69.42% |
| Operating Margin | 7.80% |
| Pretax Margin | 11.99% |
| Profit Margin | 10.69% |
| EBITDA Margin | 9.07% |
| EBIT Margin | 7.80% |
| FCF Margin | n/a |